Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Importance of Understanding Provider Variability in the Use of Neuromuscular Blocking Drugs and Reversal Agents

NCT03585348 is registered in ClinicalTrials.gov with Beth Israel Deaconess Medical Center as lead sponsor.

NCT NCT03585348
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03585348 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Importance of Understanding Provider Variability in the Use of Neuromuscular Blocking Drugs and Reversal Agents
Lead sponsor
Beth Israel Deaconess Medical Center
Phase
Observational
Overall status
Completed
Start date
June 29, 2018
Completion date
March 31, 2021
Enrollment
Not reported
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

neuromuscular blockade, residual curarisation, postoperative, surgery under general anaesthesia